MTHFR and prostate carcinoma: These results might be biologically credible, since cells carrying the C allele tend to have decreased expression of MTHFR. Validation of our initial findings in two independent cohorts further confirms that higher levels of MTHFR are associated with prostate cancer development and poorer patient outcomes.